Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT03750968Phase 2Completed
Phase 2, randomised, double-blind trial (2 arms). Primary endpoints: Change in Maternal Macular Carotenoid Levels From Enrollment to Birth of Infant, Change in Maternal Serum Carotenoid Levels From Enrollment to Birth of Infant and 1 more. Started Sep 2019; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT03750968.